The STAT3 pathway has been widely associated withproliferation and is markedly active in psoriasis patients, likely leading to anincreased IL-17 expression [50].Persistent activation of STAT3 leads to increased Th17 and keratinocyteproliferation [49]. Here, IL17A is linked to psoriasis.